# Prism Deep Dive Plan

## Direction Assessment

Today's experiments revealed four distinct value propositions:

| Direction | Finding | Novelty | Monetization potential |
|-----------|---------|---------|----------------------|
| Per-node decomposition | Fault line shifts between regimes | High | Risk attribution product |
| Yield curve (opposite signal) | Low defect = extreme consensus = fragile | Very high | Bond market tool |
| Infrastructure (load-bearing nodes) | High-defect nodes are critical, not broken | High | Grid/infra consulting |
| Drug interactions | Polypharmacy safety screening | Medium | Healthcare SaaS |

## Most Valuable Direction: Yield Curve + Financial Node Decomposition

**Why:** The yield curve finding is the most publishable and most
surprising. Nobody expects a structural metric to behave OPPOSITE on
bonds vs equities. This is a second paper.

The node decomposition is the most monetizable — risk managers want to
know WHO is driving fragility, not just THAT it exists.

Combined: "Prism tells you the market is fragile (defect level), tells
you who is making it fragile (node decomposition), and works on both
equities and fixed income (with opposite interpretation)."

## Immediate Next Steps (this week)

1. **Yield curve deep dive**: Run 2006-2023 full backtest on treasury
   ETFs. Does low defect precede every recession? Compare to 2y-10y
   spread as predictor.

2. **Node decomposition time series**: Track per-node defect contribution
   over rolling windows 2016-2021. Visualize how the fault line migrates.
   This becomes the "structural pressure heatmap" product.

3. **Write second paper draft**: "Duality Defect as Structural Consensus
   Metric: Opposite Signals in Equity and Fixed Income Networks"

## Medium-term (next 2 weeks)

4. **Real data for power grid**: Get actual grid topology from MATPOWER
   or PyPSA datasets. Run Prism on real grid, compare to known blackout
   events (2003 Northeast blackout, 2021 Texas).

5. **Drug interaction validation**: Use real DDI data from DrugBank or
   TWOSIDES dataset. Validate that high-defect drugs correlate with
   known adverse event rates.

6. **Dashboard prototype**: Simple Streamlit app showing rolling defect
   for S&P 500 + yield curve. This is the product demo.

## Paper Plan

**Paper 1 (submitted):** Prism core method + financial backtest
**Paper 2 (next):** Yield curve + node decomposition + cross-asset
**Paper 3 (later):** Infrastructure + biological networks

## Key Narrative for Product

"Prism is a structural X-ray for complex systems. It sees what
correlation cannot: the internal fractures that accumulate while
the surface looks calm. It works on any network — financial, physical,
biological — with the same formula, no training data, in milliseconds."
